How can spin-outs leverage end user feedback to refine products and validate markets? Find out as Professor Michele Barbour talks to Dr Jenny Bailey, the CEO and Co-Founder of Ferryx, a biotech company focused on the commercial production of live bacterial products for the prevention and treatment of gastrointestinal inflammation in humans and animals.

⭐Highlights

§ Discover how a chance conversation with Co-Founder Dr Tristan Cogan sparked the innovative idea behind Ferryx: the disruption of inflammatory pathways in the gut using live bacteria that flourish in the presence of iron.

§ Find out about the steps Jenny and Tristan took to protect their new intellectual property and take it from the lab to a commercial product

§ Jenny gives her perspective on the pre-accelerator ICURe programme, which encouraged her to step out of her comfort zone, engage with stakeholders, refine the project and test its market viability.

§ Hear about Ferryx’s approach to ongoing product development and testing, including clinical trials and engagement with patient feedback.

🌐 About the Enterprise Sessions

The Enterprise Sessions bring together a diverse mix of company founders and researchers who talk openly about their personal experiences of forming spin-outs and start-ups, raising capital, academic-industry partnerships and the joys of translating research discoveries into real-world impact.

The series aims to inform, inspire and challenge myths and stereotypes about research commercialisation and how businesses and universities can work together to tackle society's biggest challenges.

👍 Like, Share, Subscribe, Explore

If you found this episode inspiring or informative, please don’t forget to like and share. Visit our website or subscribe to the University of Bristol’s YouTube channel for more Enterprise Sessions.

https://www.bristol.ac.uk/enterprise-sessions

🔗 Connect with Ferryx

Ferryx website: https://www.ferryx.com/

Ferryx on LinkedIn: https://www.linkedin.com/company/ferryx/

Ferryx on X: https://twitter.com/ferryx_bristol

Next-gen Probiotics for Gut Health | The Enterprise Sessions with Jenny Bailey

ResearchPod